Upregulated glucose uptake in cancer is often observed and can be monitored with a radiolabeled analogue of glucose, 18FDG, with detection by PET, however, a well-known constraint is its ionizing radiation. Additionally, except for the trapping of that glucose analogue, PET does not provide information about subsequent glucose metabolism. Here, we demonstrated the feasibility of a simple glucose infusion protocol that allows detection of glucose oxidation in human breast cancer in vivo via 7T 13C MRS. The [U-13C]glucose infusion is performed outside of the magnet making the protocol significantly more suitable for patients compared to previous approaches that required prolonged 13C substrate infusions inside the scanner.
This abstract and the presentation materials are available to members only; a login is required.